Skip to content

Comparative Study Between Cryoablation and Radiofrequency Ablation in the Treatment of Supraventricular Tachycardia

CRYOthermy and Radiofrequency ABLation For AVNRT TrEatment

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01584154
Acronym
CRYOABLATE
Enrollment
520
Registered
2012-04-24
Start date
2012-03-31
Completion date
2017-09-30
Last updated
2015-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrioventricular Nodal Reentrant Tachycardia, Supraventricular Tachycardia

Brief summary

The purpose of this study is to compare the safety and effectiveness of cryoablation and radiofrequency ablation in the treatment of the commonest kind of supraventricular tachycardia, namely atrioventricular nodal reentrant tachycardia. The study hypothesis is that cryoablation is non-inferior to radiofrequency.

Interventions

PROCEDUREcryoablation

cryoablation with an 8mm-tip catheter

PROCEDUREradiofrequency ablation

radiofrequency ablation with a 4mm-tip catheter

Sponsors

Princess Margaret Hospital, Hong Kong
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients who are referred for catheter ablation of supraventricular tachycardia and diagnosis of AVNRT is made by cardiac electrophysiology study

Exclusion criteria

1. Patients who aged less than 18 or over 80. 2. Patients who are pregnant. 3. Patients who cannot give informed consent. 4. Patients who are judged to have severe mental impairment and cannot report symptoms of palpitation during follow-up. 5. Patients who had previous AVNRT ablation before. 6. Patients who have comorbid congenital heart disease.

Design outcomes

Primary

MeasureTime frame
treatment success rate, defined as proportion of treated patients with both atrioventricular block-free acute procedural success and mid-term success without recurrence at 6 months6 months after treatment

Secondary

MeasureTime frame
Treatment success rate at 12 months12 months after treatment

Countries

China

Contacts

Primary ContactNgai-Yin Chan, MBBS
ngaiyinchan@yahoo.com.hk852 29903725

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026